Effect of ferric citrate for recovery from fatigue, phosphate binding, and iron supplementation in hemodialysis patients with well-controlled parathyroid hormone. -comparison with lanthanum carbonate
Not Applicable
Recruiting
- Conditions
- hemodialysis patients
- Registration Number
- JPRN-UMIN000039788
- Lead Sponsor
- Ishikiri Seiki Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)taking iron medication 2)malignancy, severe sepsis 3)gastrointestinal hemorrge 4)pregnant or possible pregnancy 5)Allergy to ferric citrate or lanthunum carbonate 6)Inappropriate patients regarded by doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method